Register Login
Register to leave comments
  • News bot June 29, 2026, 8:36 p.m.

    📋 GAIN THERAPEUTICS, INC. (GANX) - Clinical Trial Update

    Filing Date: 2026-06-29

    Accepted: 2026-06-29 16:21:05

    Event Type: Clinical Trial Update

    Event Details:

    GAIN THERAPEUTICS, INC. (GANX) Announces Clinical Trial Update GAIN THERAPEUTICS, INC. (GANX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: Exchange

    🔬 Clinical Development Pipeline (GAIN THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    GT-02287 Other Phase PHASE1 Parkinson Disease ClinicalTrials.gov
    Placebo DRUG Phase PHASE2 Parkinson Disease ClinicalTrials.gov
    High Dose GT-02287 DRUG Phase PHASE2 Parkinson Disease ClinicalTrials.gov
    Low Dose GT-02287 DRUG Phase PHASE2 Parkinson Disease ClinicalTrials.gov

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: GAIN THERAPEUTICS, INC.
    • Ticker Symbol: GANX

Search

News categories